id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0147-0002,FDA,FDA-2011-D-0147,Draft Guidance for Staff Demonstrating Substantial Equivalence of New Tobacco Product; Responses to Frequently Asked Questions,Other,Guidance,2011-09-09T04:00:00Z,2011,9,2011-09-09T04:00:00Z,2011-11-09T04:59:59Z,2015-07-01T14:29:54Z,,0,0,0900006480f146e5
FDA-2011-D-0147-0001,FDA,FDA-2011-D-0147,Draft Guidance for Staff; Availability: Demonstrating Substantial Equivalence of New Tobacco Product; Responses to Frequently Asked Questions,Notice,Notice of Availability,2011-09-09T04:00:00Z,2011,9,2011-09-09T04:00:00Z,2011-11-09T04:59:59Z,2016-03-02T16:51:14Z,2011-23100,0,0,0900006480f14df8